PMV Pharmaceuticals
PMVP
PMVP
93 hedge funds and large institutions have $65.6M invested in PMV Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 26 increasing their positions, 31 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
16% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 31
19% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 26
90% less call options, than puts
Call options by funds: $2K | Put options by funds: $20K
Holders
93
Holding in Top 10
1
Calls
$2K
Puts
$20K
Top Buyers
| 1 | +$4.39M | |
| 2 | +$581K | |
| 3 | +$569K | |
| 4 |
D.E. Shaw & Co
New York
|
+$484K |
| 5 |
RC
RBF Capital
San Francisco,
California
|
+$410K |
Top Sellers
| 1 | -$3.16M | |
| 2 | -$1.66M | |
| 3 | -$1.04M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$964K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$770K |